Robertson et al., 1989 - Google Patents
Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum componentsRobertson et al., 1989
- Document ID
- 12927495585565506766
- Author
- Robertson M
- Kerr K
- Seaton A
- Publication year
- Publication venue
- Journal of Medical and Veterinary Mycology
External Links
Snippet
Spores of Aspergillus fumigatus can interfere with certain aspects of phagocytic cell function. In this study we have looked at the ability of human pulmonary macrophages to bind and kill spores of A. fumigatus which have been opsonized in untreated and heat-treated serum. For …
- 210000004215 spores 0 title abstract description 102
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Robertson et al. | Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components | |
Kogut et al. | Heterophils are decisive components in the early responses of chickens to Salmonella enteritidis infections | |
CN111662880B (en) | Clostridium perfringens bacteriophage, bacteriostatic agent containing bacteriophage, preparation method and application | |
Gambrill et al. | Mechanisms of Immunity in Typhus Infections II. Multiplication of Typhus Rickettsiae in Human Macrophage Cell Cultures in the Nonimmune System: Influence of Virulence of Rickettsial Strains and of Chloramphenicol | |
CN113351125B (en) | Citrus essential oil microcapsule and preparation method and application thereof | |
KR20050087742A (en) | Natural anti-virus and composition comprising thereof | |
US20080170996A1 (en) | Compositions and Methods for Stimulation of Lung Innate Immunity | |
Wyde et al. | Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice | |
EP1653983A1 (en) | Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil | |
Robertson et al. | Inhibition of phagocyte migration and spreading by spore diffusates of Aspergillus fumigatus | |
Sano et al. | Studies on the relationship between the estrous cycle of BALB/c mice and their resistance to Paracoccidioides brasiliensis infection | |
Husni et al. | The effect of ethanol extract of moringa leaf (moringa oleifera lam) against the activity and capacity of phagocytosis of macrofag cells and the percentage of leukosit cells of white mice | |
CN110227071A (en) | Compound borneol antibacterial agent | |
Ogidi et al. | Effect of methanol and ethanol extracts of Raphia vinifera fruit mesocarp on the hematological parameters of wistar albino rats | |
CN111821286B (en) | Liquid invisible mask with broad-spectrum bacteriostasis and preparation method and use method thereof | |
WO2023062207A1 (en) | Therapeutic and preventive compositions | |
Lawman et al. | Activity of polymorphonuclear (PMN) leukocytes during bovine herpes virus-1 induced respiratory disease: effect of recombinant bovine interferon alphaI1 | |
WO2021253643A1 (en) | Application of sulphated polysaccharides against novel coronavirus | |
DD232432A5 (en) | PROCESS FOR PREPARING THE ACTIVE SUBSTANCE OF AN IMMUNOMODULATOR MEDICAMENT | |
CH699471B1 (en) | Preparation for the prevention and / or treatment and / or prevention of the spread of respiratory diseases. | |
RU2391112C2 (en) | Method of obtaining medication for prevention and treatment of flu | |
Conzo et al. | Reovirus infection in two species of Psittaciformes recently imported into Italy | |
Eno et al. | Contribution of lymphocytes in edema induced by venom from the wasp (Belonogaster fuscipennis) | |
Okonkwo et al. | Anti-haemolytic potentials of the ethanolic leaf extract of Dracaena Arborea on Zidovudine-induced hemolysis in Wistar Albino Rats | |
EP1634590A1 (en) | Coronavirus inactivating agent |